# Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer

> **NCT00913705** · PHASE3 · COMPLETED · sponsor: **Spanish Lung Cancer Group** · enrollment: 624 (estimated)

## Conditions studied

- Non-Small-Cell Lung Cancer

## Interventions

- **DRUG:** Neoadjuvant chemotherapy (taxol and carboplatin)
- **DRUG:** Adjuvant chemotherapy (taxol and carboplatin)
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT00913705
- **Lead sponsor:** Spanish Lung Cancer Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-09
- **Primary completion:** 2007-12
- **Final completion:** 2009-06
- **Target enrollment:** 624 (ESTIMATED)
- **Last updated:** 2022-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00913705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00913705, "Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00913705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*